Leef Brands (LEEEF) EBIT (2025 - 2026)

Leef Brands' (LEEEF) quarterly EBIT came in at $1.3 million in Q1 2026, up 167.29% year-on-year from $480245.0 in Q1 2025, and up 167.29% quarter-over-quarter from -$1.9 million in Q1 2025.

Leef Brands (LEEEF) EBIT (2025 - 2026) Analysis & Trends

Leef Brands has disclosed EBIT across 2 years of filings, most recently posting $1.3 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 652.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 833.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 325.80 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 14.03 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 193.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 307.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -48.28 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -78.32 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 81.33 Mn
10 Leef Brands - - 4.62 Mn 1.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.28 Mn
Mar 31, 2025 -1.91 Mn